Cologne Register of Wearable Defibrillator (CRWD)

The wearable cardiac defibrillator (WCD) is an alternative to the implantation of cardioverter defibrillator (ICD) for patients at high risk for sudden cardiac death (mostly bridging therapy). The Cologne register of wearable defibrillator (CRWD) is a prospective register for all patient with an indication of wearable defibrillator.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myocardial Infarction Cardiomyopathies Cardiovascular Diseases Heart Diseases Infarction Ischemia Myocardial Ischemia Myocarditis Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms Vascular Diseases Ventricular Dysfunction

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Cologne

Cologne, 50937, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patients with an indication for wearable defibrillator

Exclusion criteria

childs

Treatment and study plan

Primary outcomes

Number of arrhythmic events and arrhythmic risk factors during bridging therapy with wearable defibrillator

Time frame: 3 years

Secondary outcomes

Total mortality

Time frame: 1 months and 3 months

Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]

Sponsors and collaborators

Lead sponsor

University of Cologne

Other

Collaborators

Zoll Medical Corporation

Registry information

Important dates

Study start: 2014
Primary completion: 2017
Study completion: 2018
First posted: Feb 28, 2014
Registry last updated: Oct 19, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed